Lori Pereira, Founder & Principal of Spectra Health Solutions, leverages her experience in managed care, life sciences, payer marketing and product launch, to effectively identify traditional and non-traditional reimbursement methods for rare and neuroscience diseases. Ms. Pereira is an expert in Payer New Product Development with over 15 years of managed care experience. She knows critical payer evidence must be available at launch, and is the result of effective planning during early product development. Ms. Pereira is sought out for her ability to assess clinical endpoints, comparators, and target patient populations, beginning as early as Phase 2 by organizations interested in achieving successful and affordable patient access and reimbursement for new medicines.

Ms. Pereira’s guiding principal for creating effective access solutions is proactive planning for patient affordability. She influences researchers and investors to go beyond registration requirements, and supports clients’ in their efforts to develop differentiated products that satisfy unmet medical needs and managed care evaluations. Her payer knowledge and business acumen strengthen product evidence, gain research investments, reduce research costs, and identify risks of commercial futility due to lack of product differentiation which is invaluable.

About Spectra Health Solutions

Spectra Health Solutions is a consulting firm specializing in identifying traditional and non-traditional reimbursement pathways prior to commercialization of new products for rare and neuroscience diseases. The high costs of today’s innovative medicines often create financial burden for patients; Spectra Health Solutions specializes in guiding proactive payer evidence generation through all stages of product development to achieve affordable patient access. The firm collaborates with biotech, investors, and clinical research organizations in the fields of rare diseases, neurosciences, cell therapy, and auto-immune diseases from the earliest stages of new product development through commercialization to create unique, evidence-based solutions that result differentiated products and affordable access, supported by meaningful clinical outcomes for patients, their caregivers and healthcare providers.